White House

Politics Rachel Cohrs Zhang

STAT Plus: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices

Hospitals Tara Bannow

STAT Plus: New Medicare Advantage rule is boon for providers, drag on insurers

D.C. Diagnosis Rachel Cohrs Zhang

Medicare drug price negotiation’s day in court

Politics John Wilkerson

STAT Plus: Judge skeptical of arguments against Medicare drug price negotiation

Politics Sarah Owermohle

Congressmen: This Covid hearing ‘could have been an email’

Politics Sarah Owermohle

STAT Plus: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next

Politics Sarah Owermohle

Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in

Politics Sarah Owermohle

STAT Plus: Supreme Court slates abortion pill case for March

Hospitals Tara Bannow

STAT Plus: FTC sues to block a proposed hospital deal in North Carolina

D.C. Diagnosis Rachel Cohrs Zhang

Bernie Sanders’ showdown with pharma CEOs is coming to a head

The Readout Damian Garde

STAT Plus: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect

D.C. Diagnosis Sarah Owermohle

STAT Plus: White House pharmacy under the microscope

Politics John Wilkerson

STAT Plus: Pharma’s attack on Medicare drug price negotiation might benefit Biden

Politics Brittany Trang

STAT Plus: The White House has a pharmacy — and it was a mess, a new investigation found

Health Care Inc. Bob Herman

Medicare Advantage update pushes Wall Street to reset expectations

Politics John Wilkerson

STAT Plus: FDA sets aggressive deadline for inspection overhaul

Exclusive Rachel Cohrs Zhang

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

Insurance Brittany Trang

STAT Plus: Biden changes will force health insurers to speed up and get more specific if they want to deny care

Politics John Wilkerson

STAT Plus: Copay coupons for some drugs must count toward deductibles, after Biden court move

D.C. Diagnosis Sarah Owermohle

STAT Plus: Health care negotiations on Capitol Hill are clear as mud

Politics Sarah Owermohle

STAT Plus: The new NIH director is walking a tightrope on Biden’s drug pricing vision

Business Brittany Trang

STAT Plus: Could private equity be the future of private practice? A new lobbying group thinks so

Politics Rachel Cohrs Zhang

STAT Plus: Courts will decide the future of Medicare’s power to negotiate drug prices within months

D.C. Diagnosis Sarah Owermohle

Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one

Special Report Sarah Owermohle

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

Politics Brittany Trang

STAT Plus: HHS names inaugural chief competition officer

Politics John Wilkerson

Biden’s FDA is letting Ron DeSantis import cheaper drugs from Canada. Who gets to take credit?

D.C. Diagnosis Sarah Owermohle

At JPM, how much health policy talk should we expect?

Politics Rachel Cohrs Zhang

STAT Plus: Pharmacies fear New Year’s financial squeeze from Biden administration rule